Totum Life Science Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Totum Life Science's estimated annual revenue is currently $74.3M per year.(i)
  • Totum Life Science's estimated revenue per employee is $297,000

Employee Data

  • Totum Life Science has 250 Employees.(i)

Totum Life Science's People

NameTitleEmail/Phone
1
Director Training and OperationsReveal Email/Phone
2
Director Personal TrainingReveal Email/Phone
3
PresidentReveal Email/Phone
4
Personal TrainerReveal Email/Phone
5
Sales DirectorReveal Email/Phone
6
Wellness and Life CoachReveal Email/Phone
7
KinesiologistReveal Email/Phone
8
Registered Massage TherapistReveal Email/Phone
9
PhysiotherapistReveal Email/Phone
10
Personal Trainer, Registered Kinesiologist, Level II Fascial Stretch TherapistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.5M303%N/AN/A
#2
$110.4M327-9%N/AN/A
#3
$55.8M18844%N/AN/A
#4
$114.1M338-11%N/AN/A
#5
$57.6M1948%N/AN/A
#6
$35.9M133-3%N/AN/A
#7
$29.4M109-14%N/AN/A
#8
$0.8M60%N/AN/A
#9
$708.4M18747%N/AN/A
#10
$1.1M8-47%N/AN/A
Add Company

What Is Totum Life Science?

Totum [the whole] in latin, singular nominative form of totus [whole, complete].\r\n\r\nTotum Life Science is about your life - your whole life. Our team of fitness, health, and sports rehabilitation professionals collaborate to optimize your performance and health to improve your life in every possible dimension. At Totum, we have re-defined fitness.\r\nLocated in Toronto, our upscale and modern fitness facilities feature the best equipment, a wide variety of classes and the most talented team of personal training and rehabilitation professionals in Canada.

keywords:N/A

N/A

Total Funding

250

Number of Employees

$74.3M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$39.9M250-5%N/A
#2
$88.8M25010%N/A
#3
$68.8M2501%N/A
#4
$39.9M250-5%N/A
#5
$66M25111%N/A